BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37897380)

  • 1. [Not Available].
    Frølich A
    Ugeskr Laeger; 2023 Oct; 185(42):. PubMed ID: 37897380
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review.
    Nicholson K; Liu W; Fitzpatrick D; Hardacre KA; Roberts S; Salerno J; Stranges S; Fortin M; Mangin D
    Lancet Healthy Longev; 2024 Apr; 5(4):e287-e296. PubMed ID: 38452787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Italian guidelines on management of persons with multimorbidity and polypharmacy.
    Onder G; Vetrano DL; Palmer K; Trevisan C; Amato L; Berti F; Campomori A; Catalano L; Corsonello A; Kruger P; Medea G; Nobili A; Trifirò G; Vecchi S; Veronese N; Marengoni A
    Aging Clin Exp Res; 2022 May; 34(5):989-996. PubMed ID: 35249211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation.
    Shaikh F; Pasch LB; Newton PJ; Bajorek BV; Ferguson C
    Curr Cardiol Rep; 2018 Mar; 20(5):32. PubMed ID: 29574524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015.
    van den Akker M; Vaes B; Goderis G; Van Pottelbergh G; De Burghgraeve T; Henrard S
    PLoS One; 2019; 14(2):e0212046. PubMed ID: 30753214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Multimorbidity and Polypharmacy Patterns in Young and Adult Population over a 4-Year Period: A 2011-2015 Comparison Using Real-World Data.
    Mucherino S; Gimeno-Miguel A; Carmona-Pirez J; Gonzalez-Rubio F; Ioakeim-Skoufa I; Moreno-Juste A; Orlando V; Aza-Pascual-Salcedo M; Poblador-Plou B; Menditto E; Prados-Torres A
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33919351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey.
    Kozieł M; Simovic S; Pavlovic N; Kocijancic A; Paparisto V; Music L; Trendafilova E; Dan AR; Kusljugic Z; Dan GA; Lip GYH; Potpara TS
    Ann Med; 2021 Dec; 53(1):17-25. PubMed ID: 32700579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypharmacy and Multimorbidity Among Medicaid Enrollees: A Multistate Analysis.
    Feng X; Tan X; Riley B; Zheng T; Bias T; Sambamoorthi U
    Popul Health Manag; 2018 Apr; 21(2):123-129. PubMed ID: 28683221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005-2017.
    Thomsen MK; Løppenthin KB; Bidstrup PE; Andersen EW; Dalton S; Petersen LN; Pappot H; Mortensen CE; Christensen MB; Frølich A; Lassen U; Johansen C
    Acta Oncol; 2023 Dec; 62(12):1653-1660. PubMed ID: 37874076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of parity number with multimorbidity and polypharmacy among Iranian women in the Azarcohort: a cross-sectional study.
    Faramarzi E; Somi MH; Tutunchi H; Almaspour H; Sanaie S; Asemani S
    BMC Womens Health; 2023 Jun; 23(1):295. PubMed ID: 37264361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimorbidity, polypharmacy, and mortality in older patients with pacemakers.
    Goto T; Mori K; Nakayama T; Yamamoto J; Shintani Y; Wakami K; Fukuta H; Seo Y; Ohte N
    J Arrhythm; 2022 Feb; 38(1):145-154. PubMed ID: 35222761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of an Integrated Ambulatory Care Program in Health Care and Medication Use in Patients With Multimorbidity and Polypharmacy.
    Lo YT; Chen MH; Chen PH; Lu FH; Chang CM; Yang YC
    Qual Manag Health Care; 2024 Jan-Mar 01; 33(1):18-28. PubMed ID: 37752634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study.
    Zhao Y; Wang J; Zhu X; Zhang X; Zhang Y; Zhang W; Dong Y
    BMC Geriatr; 2023 Jul; 23(1):423. PubMed ID: 37434147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dental status and its correlation with polypharmacy and multimorbidity in a Swiss nursing home population: a cross-sectional study.
    Anliker N; Molinero-Mourelle P; Weijers M; Bukvic H; Bornstein MM; Schimmel M
    Clin Oral Investig; 2023 Jun; 27(6):3021-3028. PubMed ID: 36881159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for self-reported medication adherence in community-dwelling older patients with multimorbidity and polypharmacy: a multicenter cross-sectional study.
    Liu J; Yu Y; Yan S; Zeng Y; Su S; He T; Wang Z; Ding Q; Zhang R; Li W; Wang X; Zhang L; Yue X
    BMC Geriatr; 2023 Feb; 23(1):75. PubMed ID: 36740694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacy and Multimorbidity in the Urogynecology Population and Their Effect on Pelvic Floor Symptoms.
    Zuo SW; Tellechea L; Kohn JR; Chen CCG; Abraham N; Leegant A; Halani PK; Laudano M
    Urogynecology (Phila); 2023 Jan; 29(1):80-87. PubMed ID: 36548108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of falls and hospital admissions in people with cognitive impairment in day-care: role of multimorbidity, polypharmacy, and potentially inappropriate medication.
    Scheel J; Luttenberger K; Graessel E; Kratzer A; Donath C
    BMC Geriatr; 2022 Aug; 22(1):682. PubMed ID: 35982409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
    Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
    Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the Extent of Polypharmacy and its Association With Health Service Utilization Among Persons With Cancer and Multimorbidity: A Population-Based Retrospective Cohort Study in Ontario, Canada.
    Dean T; Koné A; Martin L; Armstrong J; Sirois C
    J Pharm Pract; 2024 Feb; 37(1):35-46. PubMed ID: 35861340
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of the MULTIPAP Plus intervention in youngest-old patients with multimorbidity and polypharmacy aimed at improving prescribing practices in primary care: study protocol of a cluster randomized trial.
    Del Cura-González I; López-Rodríguez JA; Leiva-Fernández F; Gimeno-Feliu LA; Pico-Soler V; Bujalance-Zafra MJ; Domínguez-Santaella M; Polentinos-Castro E; Poblador-Plou B; Ara-Bardají P; Aza-Pascual-Salcedo M; Rogero-Blanco M; Castillo-Jiménez M; Lozano-Hernández C; Gimeno-Miguel A; González-Rubio F; Medina-García R; González-Hevilla A; Gil-Conesa M; Martín-Fernández J; Valderas JM; Marengoni A; Muth C; Prados-Torres JD; Prados-Torres A;
    Trials; 2022 Jun; 23(1):479. PubMed ID: 35681224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.